Urinalysis Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Development Potential, Price Trend, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI439
Urinalysis Market size will witness substantial expansion during the period 2021 to 2027 driven by the rising government support and the surging need for early disease detection. The gradually changing consumer food patterns have led to an increasing number of kidney diseases. There is a higher obligation for technical assistance across research laboratories, hospitals, clinics among various other healthcare settings.
The rising prevalence of urinary tract infections (UTIs), specifically in hospitals will favor the expansion of the market. Expanding geriatric population, the influx of technological advancements, and increasing adoption of user-friendly tools, are other impact-rendering factors contributing to shaping the market growth curve.
With regards to product type, the urinalysis market is segmented across instruments and consumables. The demand for consumables is expected to grow at a robust pace due to the rising prevalence of chronic diseases. The incessant need for affordable solutions has led to advancements in urine test strips. Some of the major consumables include dipsticks, disposables, and reagents. Furthermore, the growing instances of UTIs and renal dysfunction will fuel the acceptance of dipsticks.
Application wise, the market size from disease diagnosis will grow exponentially owing to the growing diabetic rate and rising penetration in the detection of a host of kidney, liver, and other ailments. The booming older population base as well as the surge in the number of health check-ups will add positive impetus to the application outlook of the market.
Based on end-use, the urinalysis market is classified across hospitals, clinical laboratories, homes, research, and academics. Hospitals are pegged to observe a significant growth rate led by ease of access to trained professionals. The provision of improved health coverages such as Medicare to acquire hospital-based medical services will substantially contribute to the market expansion.
In terms of regional segmentation, North America is expected to account for a remarkable remuneration in the urinalysis market impelled by the increasing prevalence of urinary tract infections (UTI). According to Medscape, UTIs mostly infect females and account for close to 6 million patient visits to physicians every year in the U.S. Moreover, the increasing per capita consumer incomes in the region have made way for advanced healthcare infrastructure as well as increased medical spending. The strong presence of automated devices will add to the regional growth by 2027.
Some of the global participants in the market include Bio-Rad, Roche Diagnostics, Mindray (Mindray Medical International Limited), ARKRA, and Alere (Abbott Laboratories).
These diagnostic bigwigs are constantly turning to several targeted business strategies, including mergers, partnerships, and acquisitions, along with bringing innovations in their offerings through the latest technologies to increase their geographical and competitive footprint.
For instance, in August 2020, Siemens Healthcare Diagnostics Inc. entered a distribution agreement with Sysmex America, Inc. for the promotion of the urinalysis business in North America. The partnership helped distribute the urine chemistry analyzers and their reagents from Siemens for hospital and reference laboratory use in the region.
Likewise, in April 2021, Sysmex collaborated with Inpeco for the launch of a new groundbreaking solution in urinalysis. The novelty combines the FlexLabTM automation system from Inpeco and UN-Series urinalysis solutions from Sysmex.
Impact of the COVID-19 crisis on the urinalysis market trends
The COVID-19 outbreak disrupted the global economy whilst impacting several industries across the world owing to the influx of the varying levels of stringencies of the lockdown, social distancing, and quarantine policies. However, the industry saw lucrative growth with the detection of significant abnormalities in the affected individuals before the rapid worsening of the infection. According to University Medical Center Goettingen experts, the kidneys of seriously ill patients were also affected at an early stage. This factor positively influenced the need for urinalysis amidst the pandemic.
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability